CUSIP 78464A722S&P PHARMACXPHQ4 2025
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bank Of America Corp /De/ | 356.1K | $19.95M |
| 2 | Envestnet Asset Management Inc | 246.9K | $13.83M |
| 3 | Lpl Financial LLC | 207.6K | $11.63M |
| 4 | Wells Fargo & Company/Mn | 207.2K | $11.61M |
| 5 | First Citizens Bank & Trust Co | 186.0K | $10.42M |
| 6 | Envestnet Portfolio Solutions, Inc. | 175.3K | $9.82M |
| 7 | Citigroup Inc | 155.5K | $8.71M |
| 8 | Morgan Stanley | 141.2K | $7.91M |
| 9 |
| Bnp Paribas Financial Markets |
| 89.5K |
| $5.01M |
| 10 | Cetera Investment Advisers | 81.0K | $4.54M |